Filing metadata

Accession number
0001859061-22-000002
Form type
Form 4
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
Aug 19, 2022
Reporting period
Aug 16, 2022
Description
Insider transaction

Explore SEC Filings Hub